On November 5, 2026, CITIC Securities Company Limited sold shares of SINOPHARM (01099) on the SEHK open market in an on-exchange active trade matched on the exchange, constituting a direct secondary-market dealing.
Prior to the disposal, CITIC Securities Company Limited’s long position in SINOPHARM was 134.30 million shares, representing 10.01%; following the disposal, the holding changed to 133.84 million shares, with the long position ratio falling to 9.97%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.